Next 10 |
Update on Sagaliam Acquisition Corp. ALLEN, TX / ACCESSWIRE / July 1, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) (" enzolytics.com ") (the "Company") announced today that the Company is entering into a worldwide exclusive licensing agreement for US Patent # 8067531-B2, "Inactivated pepsin frag...
ALLEN, TX / ACCESSWIRE / June 3, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com")(the "Company") is thrilled to announce that the Company and Sagaliam Acquisition Corp ("SAGA") are negotiating a landmark investment of six million US dollars ($6,000,000). This investment includes three ...
Updates on ETC Marketing, Inc and Ownership of ITV-1 and IPF ALLEN, TX / ACCESSWIRE / May 22, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) (" enzolytics.com " )(the "Company") announced today that it has entered into a Letter of Intent with Enogenesis (ENGN) for the specific use of the therape...
ALLEN, TX / ACCESSWIRE / May 2, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) (the "Company") announced today the plan to form ETC Marketing Inc. ("ETC Marketing") in partnership with Third Coast Fulfillment LLC ("TCF"), to serve the new ENZC initiative focusing on licensing of products in the medical...
Offers Update on OTC Annual Report and Business Model ALLEN, TX / ACCESSWIRE / April 23, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ( enzolytics.com )(the "Company") today disclosed that on April 9, 2024, the US District Court of Nevada dismissed the lawsuit, 22-cv-00401-GMN-DJA brought by Dim...
INFORMATION ON ENZOLYTICS, INC. BOARD OF DIRECTORS AND CHIEF EXECUTIVE OFFICER UPDATE ON FORMULATION OF NEW BUSINESS STRATEGY ALLEN, TX / ACCESSWIRE / April 12, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com ) (the "Company") today released resume information on i...
ALLEN, TX / ACCESSWIRE / January 16, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com ). Enzolytics, Inc. has partnered with The Khalpey AI Lab to improve organ recovery, longevity, and the science of aging by combining drug development with artificial intelligence. This collabor...
Provides Updates on SAGA Transaction and on Virogentics, Inc. and Biogenysis, Inc. Progress ALLEN, TX / ACCESSWIRE / November 20, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com /" https://enzolytics.com/ ). Enzolytics, Inc. (the "Company") filed an amended December 31, 2022...
2023-09-18 08:33:41 ET More on Enzolytics, Inc. Financial information for Enzolytics, Inc. SPAC Sagaliam, Enzolytics agree to raise price of unit sale to $450M For further details see: Enzolytics sells its units to Sagaliam Acquisition
COLLEGE STATION, TX / ACCESSWIRE / September 18, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com ). Enzolytics, Inc. announces today that it has executed the binding business combination agreement for the sale of Biogenysis, Inc. ("BGEN") and Virogentics Inc. ("VIRO"), the oper...
News, Short Squeeze, Breakout and More Instantly...
Update on Sagaliam Acquisition Corp. ALLEN, TX / ACCESSWIRE / July 1, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) (" enzolytics.com ") (the "Company") announced today that the Company is entering into a worldwide exclusive licensing agreement for US Patent # 8067531-B2, "Inactivated pepsin frag...
ALLEN, TX / ACCESSWIRE / June 3, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com")(the "Company") is thrilled to announce that the Company and Sagaliam Acquisition Corp ("SAGA") are negotiating a landmark investment of six million US dollars ($6,000,000). This investment includes three ...
Updates on ETC Marketing, Inc and Ownership of ITV-1 and IPF ALLEN, TX / ACCESSWIRE / May 22, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) (" enzolytics.com " )(the "Company") announced today that it has entered into a Letter of Intent with Enogenesis (ENGN) for the specific use of the therape...